Offer document and combined circular and prospectus published for the £1.68 billion shares and cash offer by Primary Health Properties for Assura
June 2025
Primary Health Properties plc is an LSE Main Market listed leading investor in modern healthcare properties in the UK & Ireland.
The company is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation.
It achieves this by investing in healthcare real estate in the UK and Ireland let on long term leases backed by a secure underlying covenant funded mostly by government bodies.
The Group’s portfolio comprises over 300 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.
Assura plc is also an LSE Main Market listed specialist healthcare property investor and developer. They enable better health outcomes through their portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
They leverage their unique understanding of the challenges facing the healthcare sector, and their two decades of experience, to deliver modern, high-quality spaces that support a healthy population.
Assura achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
On 16 May 2025, PHP announced the terms of a shares and cash offer pursuant to which PHP will acquire the entire issued, and to be issued, ordinary share capital of Assura.
Publication of the offer document and combined circular and prospectus
The Perivan shareholder communications team was delighted to work with CMS Cameron McKenna Nabarro Olswang who acted as Legal Adviser to Primary Health Properties on the offer document and combined circular, prospectus and associated ancillary documents, which were successfully published and posted to qualifying shareholders on 13th June 2025.
For more information, click here.
Perivan specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies and are a market leader for the production of documentation relating to Mergers & Acquisitions.
